Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INZY | Inozyme Pharma, Inc. | Svp, Cfo | $109K | Mar 13, 2024 | ||
OCGN | Ocugen, Inc. | Chief Financial Officer | $105K | Jan 3, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|